MIRA INFORM REPORT

 

 

Report Date :

06.04.2013

 

IDENTIFICATION DETAILS

 

Name :

INOGENT LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

Plot 28A, IDA Nacharam, Hyderabad-500076, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

01.06.2005

 

 

Com. Reg. No.:

01-046402

 

 

Capital Investment / Paid-up Capital :

Rs.161.250 Millions

 

 

CIN No.:

[Company Identification No.]

U24239AP2005PTC046402

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDI01491A

 

 

PAN No.:

[Permanent Account No.]

AABCI3898N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of providing contract research services in the area of drug discovery and development, manufacturing and trading of Active Pharma Ingredients and Intermediates.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (43)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1000000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of GVK Davix Technologies Private Limited.

 

It is well established company having a satisfactory track record. It has incurred loss from its operation during 2012. There also appears huge external borrowing. However, it receives strong financial and operational support from its affiliate ’GVK and Biosciences Private Limited’. One of India’s leading contract research space. Trade relations are reported to be fair. Business is active. Payments are slow but correct.

 

In view of strong holding company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

BBB+ (Long Term Rating)

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

24.04.2012

 

Rating Agency Name

CRISIL

Rating

A2 (Short Term rating)

Rating Explanation

Strong degree of safety and low credit risk.

Date

24.04.2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office / Factory :

Plot 28A, IDA Nacharam, Hyderabad-500076, Andhra Pradesh, India 

Tel. No.:

91-40-27171822 / 27172828 / 66929999

Fax No.:

91-40-27151270 / 66929900

E-Mail :

compliances@gvkbio.com

Website :

www.gvkbio.com

 

 

DIRECTORS

 

As on: 17.08.2011

 

Name :

Mr. Krishna Reddy Venkata Gunapati

Designation :

Chairman

Address :

H No. 6-3-250/A/1, Road No.1, Banjara Hills, Hyderabad-500034, Andhra Pradesh, Indi

Date of Birth/Age :

22.03.1937

Date of Appointment :

01.06.2005

DIN No.:

00005212

 

 

Name :

Mr. Davinder Singh Brar

Designation :

Director

Address :

Greenfields Farm, Gadaipur-Jaunapur Road, Village-Jaunapur, Tehsil-Mehrauli, New Delhi-110030, India

Date of Birth/Age :

21.08.1952

Date of Appointment :

30.09.2005

DIN No.:

00068502

 

 

Name :

Mr. Sanjay Reddy Venkata Gunapati

Designation :

Director

Address :

H No. 6-3-250/A/1, Road No.1, Banjara Hills, Hyderabad-500034, Andhra Pradesh, Indi

Date of Birth/Age :

18.11.1964

Date of Appointment :

01.06.2005

DIN No.:

00005282

 

 

Name :

Mr. Shernaz Firoze Vakil

Designation :

Director

Address :

67 E/F, Shamiana 301, Walkeswar Road, Mumbai-400006, Maharashtra, India

Date of Birth/Age :

16.06.1951

Date of Appointment :

24.11.2005

DIN No.:

00002519

 

 

MAJOR SHAREHOLDERS

 

As on: 17.08.2011

 

 

Names of Equity Shareholders

No. of Shares

GVK Davix Technologies Private Limited, India

6630000

GVK Biosciences Private Limited, India

3770000

Dai-Ichi Karkaria Limited, India

2600000

TOTAL

13000000

 

 

As on: 17.08.2011

 

Names of Preference Shareholders

No. of Shares

GVK Davix Technologies Private Limited, India

1085000

GVK Biosciences Private Limited, India

1415000

TOTAL

2500000

 

 

As on : 24.08.2012

 

Names of Preference Shareholders

No. of Shares

GVK Biosciences Private Limited, India

300000

TOTAL

300000

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 17.08.2011

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of providing contract research services in the area of drug discovery and development, manufacturing and trading of Active Pharma Ingredients and Intermediates.

 

 

Products :

Product

ITC Code

API and CCS

29420090

Research and experimental development services in chemistry

99811121

 

PRODUCTION STATUS (AS ON : 31.03.2011)

 

Particulars

Unit

Installed Capacity

Actual Production

 

 

 

 

Active Pharmaceutical Ingredients and Intermediated

Kilo Ltrs

100

117393.37

 

NOTES

 

i)         The products of the company are exempt from licensing procedures.

 

ii)       Installed capacity, being a technical matter has not been verified by the auditors. However, the management has certified the same.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         Canara Bank, Prime Corporate Branch, TSR Complex, SD Road, Secunderabad-500003, Andhra Pradesh, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

LONG TERM BORROWING

 

 

Rupee term loans from banks

207.324

332.344

SHORT TERM BORROWING

 

 

Working capital loans from banks

208.327

163.884

Total

415.651

496.228

 

 

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Brahmayya and Company

Chartered Accountant

Address :

#403 and 404, Golden Green Apartments, Ittum Manzil Colony, Hyderabad-500082, Maharashtra, India

PAN No.:

AADFB8032G

 

 

Holding Company :

GVK Davix Technologies Private Limited

CIN No.: - U72200AP2005PTC045481

 

 

Fellow Subsidiaries :

GVK Bio Sciences Private Limited

CIN No.: -U74999AP2000PTC035826

 

 

Enterprise having substantial

Interest :

Dai-Ichi Karkaria Limited

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management personnel and their relatives:

·         Orbit Travel and Tours Private Limited

·         Taj GVK Hotels and Resorts Limited

 

 

CAPITAL STRUCTURE

 

After: 17.08.2011

 

Authorised Capital : Rs.450.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.191.250 Millions

 

 

As on: 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20000000

Equity Shares

Rs.10/- each

Rs.200.000 Millions

2500000

8% Cumulative Convertible Redeemable Preference Shares

Rs.100/- each

Rs.250.000 Millions

 

 

 

Rs.450.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

16125000

Equity Shares

Rs.10/- each

Rs.161.250 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

161.250

380.000

323.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

96.991

0.000

70.000

4] (Accumulated Losses)

0.000

(80.675)

(86.402)

NETWORTH

258.241

299.325

306.598

LOAN FUNDS

 

 

 

1] Secured Loans

415.651

496.228

463.289

2] Unsecured Loans

500.000

250.000

0.000

TOTAL BORROWING

915.651

746.228

463.289

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

1173.892

1045.553

769.887

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

906.123

649.456

637.132

Capital work-in-progress

9.063

268.785

145.399

 

 

 

 

INVESTMENT

0.514

0.514

0.514

DEFERREX TAX ASSETS

64.394

50.738

23.092

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

143.2670

93.710

96.320

 

Sundry Debtors

230.383

202.611

139.661

 

Cash & Bank Balances

7.310

2.431

6.210

 

Other Current Assets

7.426

5.469

0.000

 

Loans & Advances

40.064

60.915

53.569

Total Current Assets

428.450

365.136

295.760

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

106.046

134.410

124.820

 

Other Current Liabilities

125.745

152.398

206.403

 

Provisions

2.861

2.268

1.718

Total Current Liabilities

234.652

289.076

332.941

Net Current Assets

193.798

76.060

(37.181)

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.931

 

 

 

 

TOTAL

1173.892

1045.553

769.887

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

871.166

634.393

601.588

 

 

Other Income

 

 

12.329

 

 

TOTAL                                     (A)

871.166

634.393

613.917

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption of Material

805.695

633.141

315.865

 

 

Employee Cost

 

 

131.786

 

 

Manufacturing, Selling and Administration Expenses

 

 

173.596

 

 

(Increase) / Decrease in Stock

 

 

(20.202)

 

 

TOTAL                                     (B)

805.695

633.141

601.045

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

65.471

1.252

12.872

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

68.213

50.148

35.736

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

(2.742)

(48.896)

(22.864)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

51.766

42.822

37.013

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                (G)

(54.508)

(91.718)

(59.877)

 

 

 

 

 

Less

TAX                                                                  (H)

(13.425)

(27.445)

(13.791)

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

(41.083)

(64.273)

(46.086)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(150.675)

(86.402)

(40.316)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(191.758)

(150.675)

(86.402)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

550.294

488.768

445.776

 

TOTAL EARNINGS

550.294

488.768

445.776

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

103.675

78.081

 

 

Stores & Spares

 

0.300

25.333

 

TOTAL IMPORTS

NA

103.975

103.414

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

(2.55)

(4.95)

(3.55)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(4.72)

(10.13)

(7.51)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

NA

(9.95)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(4.08)

(9.04)

(6.26)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.21)

(0.31)

(0.20)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

3.55

2.49

1.51

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.83

1.26

0.89

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

PERFORMANCE:

 

During the year, the Company achieved a turnover of Rs 871.166 Millions, showing a growth of 37.32% over the previous year. Net loss was at Rs. 41.083 Millions as against a loss of Rs. 64.273 Millions incurred during previous year. The company has continued to invest in people, processes and infrastructure which are expected to yield growth and better operating performance.

 

 

ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) AND INTERMEDIATES:

 

API business showed a healthy growth of 32% over the previous year. New markets have been identified for coverage and more customers added in the existing markets of Asia, Europe and India. The growth trend is expected to continue with the introduction of new potential products and regulatory approvals across various countries.

 

UNSECURED LOAN:

(Rs. in Millions)

Particulars

As on

31.03.2012

As on

31.03.2011

LONG TERM BORROWING

 

 

Interoperate deposits

250.000

0.000

Deposits from others

200.000

200.000

Loans and advances from related parties

50.000

50.000

Total

500.000

250.000

 

 

BANKERS CHARGES REPORT AS PER REGISTRY:

 

Corporate identity number of the company

U24239AP2005PTC046402

Name of the company

INOGENT LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot 28A, IDA Nacharam, Hyderabad-500076, Andhra Pradesh, India 

compliances@gvkbio.com

This form is for

Modification of charge

Charge identification number of the charge to be modified

10208872

Type of charge

·         Book debts

·         Movable property (not being pledge)

·         Others

Particular of charge holder

Canara Bank, Prime Corporate Branch, TSR Complex, SD Road, Secunderabad-500003, Andhra Pradesh, India

cb2657@canarabank.com

Nature of instrument creating charge

Corporate Guarantee dated 29th June 2012

Date of instrument Creating the charge

29.06.2012

Amount secured by the charge

Rs. 200.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

OCC/ODBD: Base Rate+4.50%p.a. (Floating), Presently 14.00% p.a.

Term Loan: BPLR (Floating), Presently 13.75% p.a.

ILC/FLC (DA/DP): Not Applicable, Non Fund Based Limits.

 

Terms of repayment

Working Capital Limits tenable till 28.12.2011.

Term Loan : repayment as per the Common Hypothecation Agreement dated 03.03.2010

 

Margin

Stocks-25%; Book Debts-40%; PC/PCFC-10%; ILC/FLC-5%

 

Extent and operation of the charge

Working Capital: Pari-Passu I charge along with YES Bank Limited on Inventories and Receivables valued Rs.240.000 Millions as per Stock Statement Dt. 30.09.10 (CURRENT ASSETS) and Pari-Passu II charge along with YES Bank Limited on entire Fixed Assets Present and Future having WDV of Rs. 727.100 Millions (excluding Intangibles) as per ABS as at 31.03.10 including capital work in progress (FAs)

 

Term Loan: Pari-Passu I charge on FAs and Pari-Passu II charge on CURRENT ASSETS along with YES Bank Limited.

Short particulars of the property charged (Including location of the property)

Inventory, Receivables,  Fixed Assets located at Plot 28A, IDA Nacharam, Hyderabad

Date of instrument modifying the charge

02.09.2011

Particulars of the present modification

By this Modification of Charge, Corporate Guarantee given by GVK Biosciences Private Limited in connection with the loans taken by Company for the amount not exceeding Rs. 200.000 Millions is filed.

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Electrical Equipments

·         Furniture and Fixtures

·         Laboratory Equipments

·         Library

·         Vehicles

·         Office Equipments

·         Refrigeration and AC

·         Computers

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.88

UK Pound

1

Rs.83.54

Euro

1

Rs.70.90

 

 

INFORMATION DETAILS

 

Report Prepared by :

RAJ

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

--DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

43

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.